R. Salmon

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Terry L. Smith, R. Collins, L. Holmberg, 1998, Lancet.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

A. Vincent-Salomon, M. Bollet, J. Pierga, 2008, British Journal of Cancer.

[Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie].

M. Bollet, F. Reyal, J. Pierga, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Estrogen Receptors Evolution in Neoadjuvant Aromatase Inhibitor (AI) Therapy For Breast Cancer in Elderly Women: Stability of Hormonal Receptor Expression During Treatment

C. Rosty, P. de Cremoux, R. Salmon, 2006, American journal of clinical oncology.

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.

B. Asselain, J. Pierga, R. Salmon, 1994, European journal of cancer.

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.

A. Vincent-Salomon, M. Marty, F. Bidard, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.